FDA
-
-
-
-
-
-
-
Unicycive Therapeutics (UNCY) PT Lowered to $37 at Guggenheim
-
-
-
-
-
-
-
Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR): Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDA
-
-
-
-
-
-
-
UPDATE - Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission
-
-
-
-
-
-
-
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and WEBTOON Entertainment Inc. (NA
-
-
-
-
-
-
-
Important Notice to Long-Term Shareholders of Unicycive Therapeutics, Inc. (UNCY): Grabar Law Office Investigates Claims on Your Behalf
-
-
-
-
-
-
-
Important Notice to Long-Term Shareholders of CS Disco Inc. (NYSE: LAW); Five Below, Inc. (NASDAQ: FIVE); Humana Inc. (NYSE: HUM); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office I
-
-
-
-
-
-
-
Unicycive Therapeutics to Participate in Upcoming Investor Events in September
-
324,738 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

